Free tool
Medicare drug spending
Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
18
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 18 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Testosterone Testosterone | D | $93.4M | -20% | 132,638 | $704 | $1.21 |
| Testosterone Cypionate Testosterone Cypionate | D | $41.4M | +9% | 281,637 | $147 | $8.33 |
| Xyosted Testosterone Enanthate | D | $28.9M | +30% | 6,819 | $4,239 | $301.74 |
| Aveed Testosterone Undecanoate · J3145 | B | $19.9M | +7% | 3,821 | $5,219 | $1.86 |
| Jatenzo Testosterone Undecanoate | D | $7.9M | +73% | 1,758 | $4,514 | $13.20 |
| Androgel Testosterone | D | $3.9M | -24% | 819 | $4,719 | $7.63 |
| Aveed Testosterone Undecanoate | D | $1.6M | +19% | 246 | $6,423 | $622.58 |
| Depo-Testosterone* Testosterone Cypionate* · J1071 | B | $1.3M | -24% | 31,841 | $40 | $0.02 |
| Testopel Testosterone | D | $1.3M | +23% | 508 | $2,482 | $108.42 |
| Testim Testosterone | D | $971K | -8% | 245 | $3,964 | $3.72 |
| Testosterone Enanthate Testosterone Enanthate | D | $796K | -6% | 3,734 | $213 | $12.86 |
| Tlando Testosterone Undecanoate | D | $671K | -13% | 223 | $3,009 | $6.01 |
| Natesto Testosterone | D | $490K | -17% | 160 | $3,060 | $38.41 |
| Methitest Methyltestosterone | D | $357K | +61% | n/a | n/a | $67.18 |
| Methyltestosterone Methyltestosterone | D | $309K | -21% | 18 | $17,193 | $53.62 |
| Depo-Testosterone Testosterone Cypionate | D | $162K | -84% | 1,962 | $83 | $10.10 |
| Testosterone Enanthate Testosterone Enanthate · J3121 | B | $21K | -25% | 515 | $41 | $0.05 |
| Androderm Testosterone | D | $18K | -99% | 29 | $631 | $15.54 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.